Article
MET-Oncogenic and JAK2-Inactivating Alterations Are Independent Factors That Affect Regulation of PD-L1 Expression in Lung Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research - 15 Sept 2018
Saigi Maria, Alburquerque-Bejar Juan J, Mc Leer-Florin Anne, Pereira Carolina, Pros Eva, Romero Octavio A, Baixeras Nuria, Esteve-Codina Anna, Nadal Ernest, Brambilla Elisabeth, Sanchez-Cespedes Montse
Abstract excerpt
Purpose: The blockade of immune checkpoints such as PD-L1 and PD-1 is being exploited therapeutically in several types of malignancies. Here, we aimed to understand the contribution of the genetics of lung cancer to the ability of tumor cells to escape immunosurveillance checkpoints.Experimental Design: More than 150 primary non-small cell lung cancers, including pulmonary sarcomatoid carcinomas, were tested for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
